𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differentiation, proliferation and apoptosis in primary and recurrent primitive neuroectodermal tumors of childhood

✍ Scribed by David Székessy; Gisela Stoltenburg-Didinger

Publisher
Springer
Year
2001
Tongue
English
Weight
454 KB
Volume
17
Category
Article
ISSN
0256-7040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Atypical cytogenetic aberrations in two
Atypical cytogenetic aberrations in two childhood peripheral primitive neuroectodermal Tumors
✍ Dr. Jeffrey C. Murray; Claire Langston; Zoann E. Dreyer; Charles T. Stephenson; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 810 KB

## Abstract Atypical cytogenetic abnormalities were detected in peripheral primitive neuroectodermal tumors (PPNET) of the extremity in two children. One had an osseous tumor with a balanced reciprocal translocation, t(5;9)(q22;q32), and had a complete response to therapy. The other had a non‐osseo

Glial differentiation predicts poor clin
Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors
✍ Dr Anna J. Janss; Anthony T. Yachnis; Jeffrey H. Silber; John Q. Trojanowski; Vi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 976 KB

Primitive neuroectodermal tumors (PNETs) of the central nervous system, including medulloblastomas (PNET/MB), are the most common malignant brain tumor of childhood. These tumors often express proteins characteristic of glial differentiation (glial fibrillary acidic protein, GFAP), neuronal differen

Results of treatment of children with re
Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine
✍ Ilene B. Lefkowitz; Roger J. Packer; Kathy R. Siegel; Leslie N. Sutton; Luis Sch 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 648 KB

Primitive neuroectodermal tumors/medulloblastoma (PNET/MB) are the most common posterior fossa tumors in childhood. Despite surgery and radiation therapy, 40% to 50% of children with PNET/MB will have recurrent disease. Various chemotherapeutic agents are transiently effective in recurrent PNET/MB,

Bone morphogenetic proteins-2 and -4 att
Bone morphogenetic proteins-2 and -4 attenuate apoptosis in a cerebellar primitive neuroectodermal tumor cell line
✍ Mark R. Iantosca; Clifton E. McPherson; Shih-Yieh Ho; Gerald D. Maxwell 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Similarities between primitive neuroectodermal tumors and central nervous system (CNS) progenitor cells have evoked interest in the response of these tumors to endogenous growth factors. The bone morphogenetic proteins (BMPs) have recently been found to regulate survival and differentiation of CNS p